Breaking News, Collaborations & Alliances

PharmaEngine, Nanobiotix in Asia-Pac NBTXR3 Pact

PharmaEngine to conduct Asia-based clinical development services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

French Nanobiotix S.A. has entered into a strategic partnership with PharmaEngine, Inc. for the development of NBTXR3, its lead product from its NanoXray pipeline. PharmaEngine will use its Asia-based clinical development services to conduct further clinical studies.   PharmaEngine will receive exclusive rights to develop and commercialize NBTXR3 in the Asian-Pacific region, including Australia, China, India, Japan, Korea, Taiwan and other countries, while Nanobiotix retains exclusive rights for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters